Buscar
Congreso SOLACI
HomeCoronary diseaseAcute coronary syndromes

Acute coronary syndromes

Ver Categoría

Acute coronary syndromes

SOLACI CACI | How to recommend CABG or PCI on Left Main Trunk + multi-vessel disease: CCF experience and daily practice

Leia os artigos mais destacados do primeiro dia do Congresso SOLACI-CACI 2017. Neste caso, consulte a apresentação do...
solaci -
Ver más
Acute coronary syndromes

SOLACI CACI 2017 | Left main trunk and Multi-Vessel Disease: Improving Decision Making with SYNTAX 2 Score

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Patrick...
solaci -
Ver más
Acute coronary syndromes

SOLACI CACI 2017 | How did Europe transform the treatment of STEMI patients?

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Andreas...
solaci -
Ver más
Acute coronary syndromes

PCI Mortality and Volume in One Center: Associated?

The relationship between procedure volume and prognosis after a percutaneous coronary intervention remains unclear. Intuitively, we tend...
solaci -
Ver más
Acute coronary syndromes

Prior assistance with Impella 2.5 lowers 30-day mortality in cardiogenic shock due to unprotected left main coronary artery lesion

Courtesy of Dr. Carlos Fava. The prevalence of cardiogenic shock in acute myocardial infarction (MI) is 7%-10%, and it is associated...
solaci -
Ver más
Acute coronary syndromes

The transradial approach reduces the risk of kidney injury in acute patients

It remains unclear whether transradial access, compared with transfemoral access, presents a different risk of post-procedural kidney...
solaci -
Ver más
Acute coronary syndromes

Transradial access shows no benefit of bivalirudin

The aim of this study was to compare bivalirudin against heparin in patients with ST elevation acute...
solaci -
Ver más
Acute coronary syndromes

Leaders Free ACS: Good Results for the Polymer-Free Stent at 2 Years in ACS

 Courtesy of the SBHCI. Guidelines recommend dual antiplatelet therapy for a year in patients admitted with coronary acute...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Dr. Omar Tupayachi - 0
Coronary perforations during PCI are one of the most dreaded complications in interventional cardiology, especially in bifurcations. Though rate, this critical situation requires an...

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Noticias Institucionales

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad